Recap: Cushman & Wakefield Q4 Earnings

Cushman & Wakefield (NYSE:CWK) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:05 PM. Here’s…

Cushman & Wakefield (NYSE:CWK) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Cushman & Wakefield beat estimated earnings by 12.5%, reporting an EPS of $0.45 versus an estimate of $0.4.

Revenue was down $95.00 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 8.7% increase in the share price the next day.

Here’s a look at Cushman & Wakefield’s past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.23 0.21 0.20 0.45
EPS Actual 0.21 0.22 -0.04 0.46
Revenue Estimate 1.65B 2.35B 1.75B 1.85B
Revenue Actual 1.59B 2.41B 1.50B 2.65B

To track all earnings releases for Cushman & Wakefield visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Beam Therapeutics Expects Cash, Cash Equivalents, And Marketable Securities Of $1.1B Will Enable The Company To Fund Its Anticipated Operating Expenses And Capital Expenditure Requirements At Least Into 2025

This expectation includes funding directed toward reaching each of the key milestones for BEAM-101, BEAM-201, BEAM-301 and BEAM-302 described above, as well as continued investments in platform advancements and

BEAM